To treat or not to treat Alzheimer's disease by the ketogenic diet? that is the question
Marzena U(l)amek-Kozio(l)1
Ryszard Pluta2
1.Laboratory of Ischemic and Neurodegenerative Brain Research,Mossakowski Medical Research Centre, Polish Academy of Sciences, Warsaw, Poland;First Department of Neurology, Institute of Psychiatry and Neurology, Warsaw, Poland2.Laboratory of Ischemic and Neurodegenerative Brain Research,Mossakowski Medical Research Centre, Polish Academy of Sciences, Warsaw, Poland
摘要：Alzheimer's disease (AD) and current treatments:AD is a serious neurological disorder worldwide that affects about 26 million people,and whose prevalence has been calculated to quadruple by 2050,thus reaching over 1％ of the total population,with the highest prevalence occurring in both adults and elderly (Pluta et al.,2018).Neurodegenerative processes of the sporadic form of AD probably start 20 years before the clinical onset of the disorder (Pluta et al.,2018).
机标关键词：
论文发表日期：2020-05-28
在线出版日期：2025-08-15（本平台首次上网日期，不代表文献的发表时间）
页数：2( 857-858 )